The intelligence layer for pharma.
Less data wrangling. More science.
NeuraTrace connects pharmaceutical data and evidence, uses AI to surface the context that matters, and helps keep traceable audit evidence ready when you need it.
Your batch is connected. Your evidence isn't.
Quality evidence lives across ERP, LIMS, chromatography systems, MES, QMS and documents. Reviewers still have to find it, reconcile it and interpret it by hand — every batch, every time.
Chasing records
Hours spent locating the evidence behind one decision, across five or more systems and a filing cabinet.
Reconciling data
Manual cross-checks between records, results and specifications, with no shared view of what belongs together.
Managing backlogs
Limited visibility into what is blocked, why it is blocked, and which batches actually need a reviewer's attention.
Preparing for audits
Reconstructing the trail months or years later, when the reviewer who signed it has moved on.
The reviewer becomes the integration layer.
From scattered records to a review you can explain.
Find what needs attention
Missing evidence, inconsistent values and the quality events that bear on this batch, surfaced before the reviewer opens it.
See the evidence
Every finding traces to its source record, the system it came from, and the requirement it was checked against.
Keep QA in control
The reviewer investigates, records an observation and makes the decision. NeuraTrace does not recommend release.
Reconstruct the story
When someone asks why a decision was made, the supporting evidence is already assembled and still producible.
Explore a batch.
Pick a related record. This is how a connected review behaves — follow a relationship and the context comes with it, instead of opening another system.
All identifiers and relationships shown here are illustrative. This is a concept of how a connected review behaves, not live NeuraTrace data or a claim about current functionality.
One review. Four reasons to want it.
Spend less time chasing evidence. More time reviewing quality.
Find the relevant batch records, analytical results, deviations and supporting documents in one connected review.
Clear the review backlog without lowering the quality bar.
See which batches need attention, why they need it, and what evidence is missing or inconsistent.
Know where quality risk is building.
Identify evidence gaps, unresolved exceptions and recurring issues across batches and source systems.
Be ready to show the evidence behind a decision.
Reconstruct the records, source references and review rationale without a last-minute scramble across departments.
Show the impact. Don't just claim it.
We measure evidence-gathering time, review completion, exception resolution and audit preparation against your own baseline — and publish validated results only once we have them. In the meantime, the arithmetic of your current workflow is worth looking at.
This estimates the value of released staff capacity, not guaranteed cash savings. It excludes implementation effort, product fees, and any further benefit from avoided delays, rework or audit preparation. It is not a NeuraTrace customer result.
Every finding names its source.
A reviewer can follow any conclusion back to the record it came from, in the system it came from — and still do it in seven years, when an inspector asks and the person who signed it has left.
Configured at site onboarding
Audit Trail module
Sequence 04 run 18 Aug 2026
Linked automatically, not by hand
Two-level workflow
Reviewer and approver are separate roles with separate records. Neither can authorise a section while a flag is unaddressed.
Observation is mandatory
Every flagged item must be opened and answered in writing before the section closes. It is a gate, not a suggestion.
Provenance on every value
Each figure names the system it was retrieved from, so reconstruction never depends on anyone's memory.
Batch release first. The same evidence serves what comes next.
One application is live at our design partner's site. Everything else is labelled roadmap, and stays that way until it runs against real batches.
Batch Release
LiveDeviation Investigation
RoadmapInspection Readiness
RoadmapBuilt with an active QA reviewer in the room.
Fragmented enterprise systems, regulated decisions and applied AI are three different problems. Pharma quality needs all three solved at once — which is why the team is built the way it is, with a practising reviewer involved from the first screen rather than consulted at the end.
See NeuraTrace on a batch you already released.
You don't need to connect your enterprise to find out whether this is useful. Give us one batch your team has already reviewed, and compare what NeuraTrace surfaces against what they found. Read-only, inside your network, on your terms.